PatchSiren cyber security CVE debrief
CVE-2026-83149 Oracle Corporation CVE debrief
A critical vulnerability exists in Oracle Application Testing Suite version 13.3.0.1. A low-privileged attacker with network access via HTTP can compromise the suite, potentially impacting additional products. Successful attacks can result in unauthorized access to critical data, update, insert or delete access to some data, and partial denial of service.
- Vendor
- Oracle Corporation
- Product
- Oracle Application Testing Suite
- CVSS
- CRITICAL 9.1
- CISA KEV
- Not listed in stored evidence
- Original CVE published
- 2026-09-15
- Original CVE updated
- 2026-09-21
- Advisory published
- 2026-09-15
- Advisory updated
- 2026-09-21
Who should care
Defenders responsible for Oracle Application Testing Suite deployments, particularly those with version 13.3.0.1, should assess exposure and prioritize remediation. IT teams and security professionals managing Oracle products should verify the effectiveness of existing controls and monitor for potential attacks.
Why it matters
CVE-2026-83149 is a critical vulnerability in Oracle Application Testing Suite version 13.3.0.1. Defenders should prioritize remediation and verify existing controls to prevent potential data breaches and service disruptions.
- Potential unauthorized access to critical data
- Possible update, insert or delete access to some data
- Partial denial of service (DOS) of Oracle Application Testing Suite
Technical summary
The vulnerability in Oracle Application Testing Suite version 13.3.0.1 allows a low-privileged attacker with network access via HTTP to compromise the suite. Successful attacks can result in unauthorized access to critical data, update, insert or delete access to some data, and partial denial of service. The CVSS 3.1 Base Score is 9.1 with Confidentiality, Integrity, and Availability impacts. The vulnerability is easily exploitable and allows attackers to compromise the suite, potentially impacting additional products.
Defensive priority
High priority remediation is recommended for Oracle Application Testing Suite version 13.3.0.1. Defenders should assess exposure and verify the effectiveness of existing controls.
Recommended defensive actions
- Remediate Oracle Application Testing Suite version 13.3.0.1 to prevent exploitation
- Verify the effectiveness of existing controls and access restrictions
- Monitor for potential attacks and anomalies
- Review compensating controls for exposed systems while remediation is scheduled and verified
- Check relevant monitoring, detection, and logs for exposed assets that need extra review
- Track exceptions, retest remediated assets, and close the item only after evidence is documented
- Confirm whether affected product deployments exist in managed environments and assign an owner for follow-up
Evidence notes
The CVE record and NVD entry provide details on the vulnerability. Oracle's security alert page may offer additional information. Defenders should verify the effectiveness of existing controls and monitor for potential attacks. The vulnerability affects Oracle Application Testing Suite version 13.3.0.1, and its scope may change, impacting additional products. Successful attacks can result in unauthorized access to critical data, update, insert or delete access to some data, and partial denial of service.
Sources and references
Verified primary and authoritative sources
-
CVE-2026-83149 CVE Program record
Publisher, destination, and source semantics verified
URL: https://www.cve.org/CVERecord?id=CVE-2026-83149
CVE Program - Official CVE Program record with source-provided CVE metadata.
-
CVE-2026-83149 NVD vulnerability detail
Publisher, destination, and source semantics verified
URL: https://nvd.nist.gov/vuln/detail/CVE-2026-83149
NIST National Vulnerability Database - Official NIST NVD detail page and source-specific vulnerability assessment.
Supplemental references
-
Source reference
Unverified legacy reference
URL: https://www.oracle.com/security-alerts/cspusep2026.html
Methodology and review provenance
AI-assisted synthesis based on stored public vulnerability evidence. System validation, approval state, and publication status do not by themselves establish human review of this revision. PatchSiren helps prioritize defensive review and does not prove exposure or remediation on any system.